Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study.

Judith Kirstein,Miriam Pina,Judy Pan,Emilia Jordanov,Mandeep S. Dhingra

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study.

2020

Judith Kirstein
Miriam Pina
Judy Pan
Emilia Jordanov
Mandeep S. Dhingra

MenACYW-TT is an investigational quadrivalent meningococcal conjugate vaccine intended for the prevention of invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y in individuals ...

Keywords:

Immunogenicity
Tetanus
Meningococcal conjugate vaccine
Toxoid
Randomized controlled trial
Immunology
Invasive meningococcal disease
Virology
Medicine
Conjugate vaccine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations